This article has Open Peer Review reports available.
Effects of edible bird's nest (EBN) on cultured rabbit corneal keratocytes
© Abidin et al; licensee BioMed Central Ltd. 2011
Received: 14 March 2011
Accepted: 12 October 2011
Published: 12 October 2011
There has been no effective treatment or agent that is available for corneal injury in promoting corneal wound healing. Previous studies on edible bird's nest extract (EBN) had reported the presence of hormone-like substance; avian epidermal growth factor that could stimulate cell division and enhance regeneration. This study aimed to investigate the effects of EBN on corneal keratocytes proliferative capacity and phenotypical changes.
Corneal keratocytes from six New Zealand White Rabbits were isolated and cultured until Passage 1. The proliferative effects of EBN on corneal keratocytes were determined by MTT assay in serum-containing medium (FDS) and serum-free medium (FD). Keratocytes phenotypical changes were morphologically assessed and gene expression of aldehyde dehydrogenase (ALDH), collagen type 1 and lumican were determined through RT-PCR.
The highest cell proliferation was observed when both media were supplemented with 0.05% and 0.1% EBN. Cell proliferation was also consistently higher in FDS compared to FD. Both phase contrast micrographs and gene expression analysis confirmed the corneal keratocytes retained their phenotypes with the addition of EBN.
These results suggested that low concentration of EBN could synergistically induce cell proliferation, especially in serum-containing medium. This could be a novel breakthrough as both cell proliferation and functional maintenance are important during corneal wound healing. The in vitro test is considered as a crucial first step for nutri-pharmaceutical formation of EBN-based eye drops before in vivo application.
The cornea comprises of three distinct layers: the epithelium, the stroma and the endothelium. Each layer provides specific properties which are crucial to the optimal functionality of the cornea in normal vision while acting as a protective barrier from external environment . The corneal stroma makes up 90% of the corneal volume and is filled with keratocytes bound by extracellular matrix which forms the structural backbone of the cornea [2, 3]. Keratocytes are mesenchymal-derived cells of the corneal stroma responsible for the synthesis and maintenance of the extracellular matrix (ECM) components . Normal, quiescent keratocytes residue between collagen lamellae of the corneal stroma as a sparse population of flattened-cells , connecting to one other through a network of extensive processes . The keratocytes have low cell turnover with undetectable cell remodelling overtime [5, 7, 8]. These homeostatic characteristics are important for corneal transparency. During deep injuries in which the epithelial basement membrane is disrupted, these keratocytes will change their morphological characteristics into 'activated' phenotype which resembles the fibroblasts: fusiform-shaped with multiple nucleoli and lack of cytoplasmic granules . The activation of fibroblasts from quiescent keratocytes is also observed in cell culture models which show similar phenotypical changes of keratocytes during wounding. This was done by adding serum into the culture medium and by further passaging these cells, which were initially maintained in a serum-free condition [3, 7].
The cornea can be damaged either by limited injury such as abrasions and localized burns or by extensive injury in terms of surface or depth . Following stromal injury, keratocytes are stimulated to either undergo apoptosis or to lose their quiescence and change into activated fibroblasts . The remaining keratocytes then begin to replenish through cell proliferation, followed by cell migration to cover the wounded area . The process of remodelling and tissue repair involves laying down of collagens, proteoglycans and other substances in the wounded area . Unfortunately, topical agents available in the market for treating corneal wounds and ulcers inhibit the healing process because of the presence of preservatives such as benzalkonium chloride (BAK) and polyquartenium-1. These preservatives were used to prevent bacterial contamination and were usually found in multidose preparations . A study by Collin (1986) revealed that BAK should not be used on corneas with abnormal epithelium as it could cause extensive damage involving the mitochondria, other organelles and the outer cell membrane of the corneal stromal cells .
The EBN which was derived from swiftlet's saliva has been a renowned heritage delicacy for many generations since the early Chinese dynasties. Although it has a long history as therapeutic herbal medicine and highly-acclaimed for its beauty-rejuvenating applications, very limited research has been done to scientifically prove its medicinal properties. Ancient Chinese literatures described EBN as a precious food because of its unique medicinal property in treating tuberculosis, gastric ulcers and bleeding in the lungs. Greater discoveries on EBN were elucidated by modern science among which was the discovery of the first known avian epidermal growth factor found in purified swiftlet nest extracts [16, 17]. EBN was found to have mitogenic effects on human peripheral blood monocytes following stimulation with Concanavalin A and Phytohemagglutinin A . Using EBN and a formulation containing pearl powder, it was shown there was an elevation of DNA synthesis of the T-lymphocytes and circulating immunoglobulin M level in mice, implying the immunoenhancing effects . Guo et al. in 2006 had found out that EBN was able to prevent influenza viruses in vitro via its sialic acid component . Most recently, a study on the effect of EBN on intestinal cells using Caco-2 cell line showed the highest proliferation in commercial EBN compared to the unprocessed EBN obtained from four different zones of Peninsular Malaysia. These findings suggested the presence of growth stimulating components in the commercial EBN which could either be naturally present or because of adulteration .
Presently, no study has been done to evaluate the potential value of EBN in promoting corneal cell growth and proliferation that are essential during wound healing. If the EBN can be proven to potentiate cell proliferation, particularly in corneal keratocytes, it will be a major breakthrough in finding another scientific value behind this natural product. Our ultimate aim is to commercialize the EBN-based eye drop as an excellent medical treatment derived from natural sources which could boost the nutri-pharmaceutical industry. Thus, our objective was to identify the ideal dosage of EBN extract for corneal keratocytes using the MTT method as our reference for future studies in in vitro corneal wound healing model. At the same time, we tried to prove the EBN did not alter the characteristics of the corneal keratocytes during cell proliferation.
EBN extract coded as EHMG was obtained from Institute of Bioproduct Development, Universiti Teknologi Malaysia (UTM). This extract was prepared under a nondisclosure procedure using an in-house developed method adapted from Oda et al. 1998 . Briefly, the EBN was ground to dust using mortar, pestled and sieved through a 0.4 mm wire mesh to separate the feathers and other impurities. The ground EBN then underwent an aqueous extraction process at a high temperature of 80°C before centrifugation and was then stored at 4°C until used.
This study was approved by the Universiti Kebangsaan Malaysia Animal Ethics Committee (project code: UKMAEC Approval Number PP/ANAT/2010/NORZANA/24-AUGUST/321-AUGUST-2010-AUGUST-2011). The corneal tissues were harvested from six New Zealand white rabbits' eyes from the local animal slaughterhouse and were processed using the techniques reported by Norzana et al. (2007) .
The stromal tissues were obtained from the corneal tissues after the removal of the loosened epithelial sheets. They were washed thoroughly with phosphate buffered solution (PBS, pH 7.2, Gibco Invitrogen, USA) and each stromal tissue was cut into half. Each piece was digested with 0.3% collagenase type I, incubated at 37°C with intermittent gentle shaking until all the stromal tissues were digested. The stromal cell suspension was centrifuged at 500 × g for 10 minutes; the resultant pellet was washed with phosphate buffered solution (PBS, pH 7.2, Gibco Invitrogen, USA) to remove any residual enzyme and resuspended in the PBS for total cell quantification with haemacytometer (Weber Scientific Int, Ltd. Middlx, England). Cell viability was determined by trypan blue dye (Gibco Invitrogen, USA) exclusion test. Viable stromal cells were seeded in six well-plates (BD Falcon, Franklin Lakes, NJ) with seeding density of 5 × 104 cell/cm2 in FD medium [F12: DMEM (Dulbecco Modified Eagle's Medium)]. All cultures were maintained in 5% CO2 incubator (Jouan, Duguay Trouin, SH) at 37°C under 95% humidity and the media were changed every three days. Once confluent, the primary culture (P0) was trypsinized using 0.05% trypsin-EDTA and counted for total cell number and viability. The culture was then passaged (P1), under the same condition as the primary culture. The morphological features were examined at day 1 using inverted phase contrast microscope (Carl Zeiss, Germany).
Cell Viability and Proliferation Assay
The 3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT) assay was used to assess the effects of EHMG-coded EBN on corneal keratocytes' proliferative capacity and viability. The cells were seeded overnight in 96-well cell culture plate (Cellstar, Greiner Bio-one, Germany) with the seeding density of 5 × 103 cells cm-2. Several concentrations of EHMG-coded EBN using dilution factor of 2 were added in the following day using 2 different media, serum-containing media (FDS) and serum-free media (FD). The cells were incubated at 37°C in a humidified incubator 5% CO2 atmosphere for 72 hours until confluence.
Then, each well (including controls) was added with 10 μl MTT solution, mixed and incubated at 37°C in a humidified incubator 5% CO2 atmosphere for another 4 hours. Following incubation, 200 μl Dimethylsulfoxide (DMSO) was added to each well to dissolve the purple formazan and the absorbance was measured at 570 nm. The total viable cell number was directly proportional to the level of absorbance produced by the purple formazan precipitate. EBN concentration which provided the highest cell proliferation was used for functional evaluation on keratocytes by mRNA expression assessment.
Total RNA Extraction and Gene Expression Analyses
Total RNA from cultured keratocytes in A) Serum-containing medium, FDS, B) FDS plus 0.05% EBN, C) Serum-free medium, FD and D) FD plus 0.05% EBN were isolated using TRI Reagent (Molecular Research Center, Cincinnati, USA) according to a previously published protocol. Polyacryl carrier (Molecular Research Center) was added to each extraction to precipitate the total RNA and the extracted RNA pellet was then washed with 75% ethanol and dried before dissolving it in Rnase and Dnase free distilled water (Invitrogen, Carlsbad, USA). The RNA was quantified and the purity was determined by Nanodrop ND-100 spectrophotometer (Wilmington DE, USA) and stored at -80°C before use. Complementary DNA was synthesised from 100 ng of Total RNA with SuperScript III reverse transcriptase (Invitrogen) according to the protocol recommended by the manufacturer. In brief, the protocol conditions were 10 minutes at 23°C for primer annealing, 60 minutes at 50°C for reverse transcription and 5 minutes at 85°C for reaction termination.
Description of primers used in RT-PCR for gene expression analyses.
Primers 5'→ 3'
PCR product (bp)
F: caa cga att tgg cta cag ca
R: aaa ctg tga aga ggg gca ga
Collagen Type 1
F: gcg gag agt act gga ttg acc
R: cac acg tgc ttc ttc tcc ttg
F: gag tgg cat gat tca gtg agc
R: gag tag tcg tcc cct ctt gga
F: ctg cag ctt acc cac aac aag
R: ggt tga agc tca agt cca ggt
All the data were tested for statistical significance using Statistical package for Social Sciences (SPSS) version 18. Values were expressed as mean ± standard error of mean (SEM) and were analyzed using Student's t-test and One-way Analysis of Variance (ANOVA). A p value of less than 0.05 was considered significant.
Cell Viability and Proliferative Assay
On the other hand, corneal keratocytes cultured in FD exhibited the highest proliferative activity when supplemented with 0.05% EBN, followed by 0.1% EBN and 0.2% EBN [Figure 1B], but these results were not significant (p > 0.05) when compared to FD alone. Similar cessation in proliferative capacity of corneal keratocytes was found when tested with a range of EBN concentrations from 0.4% EBN to 100% EBN. However, the values were not significant when compared to the control (p > 0.05).
One important aspect which could also cause higher cell proliferative activity was because of the presence of serum. Corneal keratocytes cultured in FDS showed higher cell proliferative activity compared to FD, with or without the additional EBN [Figure 1C]. The differences were significant among cells cultured in FDS and FD only (p = 0.001), and in media with 0.05% EBN (p = 0.011). There was possibility of mitogenic effect of EBN to corneal keratocytes at this stage, thus promoting higher cell growth. Although the cells cultured with EBN in FDS continuously gave better proliferation compared to those cultured in FD, these differences were only significant between 0.8% to 4% and 25% to 50% EBN (p < 0.05).
Phase contrast micrographs
Gene Expression Analysis
The cornea is exposed to injuries by various ways which includes mechanical insults, infections or following refractive surgical techniques like laser in situ keratomileusis (LASIK) or photorefractive keratectomy. Ideally, when injuries occur to the cornea, the cell layers should regenerate perfectly with the new layers formed resemble the original layers before injury. Unfortunately, most corneal injuries healed by tissue repair were not histologically and physiologically identical with the uninjured corneal tissue. This results in scar tissue formation and opacity of the cornea thus compromising its optical function . Many researchers have proposed different ideas to overcome this problem, for e.g. amniotic membrane application [25–27] or addition of certain growth factors [e.g. epidermal growth factor (EGF), fibroblast growth factors (FGF), transforming growth factors alpha (TGF-α)] [28–31]. However, controlled randomized long-term trials involving large number of patients are still needed to substantiate their clinical importance in promoting effective corneal wound healing [28, 31].
The major ingredients of EBN are glycoproteins whereas the major component of carbohydrate in EBN is sialic acid by 9% . Other carbohydrate components include N-acetylgalactosamine (galNac) (7.2%), N-acetylglucosamine (glcNac) (5.3%), galactose (16.9%) and fucose (0.7%) . Amino acids and mineral salts are also found in the EBN, mainly sodium and calcium, with low levels of magnesium, zinc, manganese and iron . Kathan & Weeks in 1969 have found three nonessential amino acids (aspartic acid, glutamic acid and proline) and two essential amino acids (threonine and valine) in EBN. They play an important role in facilitating normal body function such as repairing and providing immunity .
We showed that cultured rabbit corneal keratocytes in FDS reached their highest level of cell proliferation with 0.05% and 0.1% EBN (Figure 1A), while those cultured in FD had similar findings with 0.05% EBN alone (Figure 1B). These results were in conformity with the earlier findings of epidermal growth factor (EGF)-like activity using aqueous extract of EBN in stimulating the DNA synthesis of 3T3 fibroblast in vitro . EGF is a 6 kDa polypeptide hormone produced by the salivary and Brunner's glands in the gastrointestinal tract  and is also found in human platelets and macrophages . It plays an important role in the normal cellular processes (i.e proliferation, differentiation and development)  as well as during inflammation, wound healing and tissue regeneration . Pancholi et al. (1998) has found out that EGF was able to stimulate cell proliferation of cultured keratocytes in a dose-dependent manner . In general, growth factors are effective at very low concentrations while exerting their effects locally . This is in accordance with our findings which showed the highest proliferative activity in keratocytes' culture media supplemented with 0.05% EBN. Concurrently, there was a 70% increase in corneal keratocytes cultured in FDS containing 0.05% EBN compared to only 32% increase of keratocytes cultured in FD containing the same amount of EBN (Figure 2). Culture medium is an important single factor in cell and tissue culture because it supplies all essential nutrients for cell metabolism, growth and proliferation [39, 40]. It comprises of all types of soluble molecules - nutrients and salts, hormones and growth factors . Much of these essential nutrients, hormones and growth factors are being supplied by the serum, which is commonly supplemented to the culture medium [42, 43]. Hormonal factors in serum potentiate cell growth and proliferation while promoting differentiation [44, 45]. The difference in keratocytes proliferation in different media was clearly shown in this study. Similar findings were observed in several hybridoma cell lines in which the specific growth rate and cell productivity had decreased concomitantly with the reduction in serum concentration without medium supplement replacement [46–48]. Besides, EBN may have a synergistic effect in promoting cell proliferation when added into serum-containing medium.
We also observed the corneal keratocytes displayed morphological features of 'activated' fibroblasts when cultured in serum-containing media added with 0.05% EBN. Similar morphological features were observed in keratocytes cultured in serum-free media because of the effect of pasaging. It was important to ensure that EBN besides inducing proliferation of corneal cells was also capable to maintain their phenotypes and functionality by synthesizing and organizing stromal constituents crucial in maintaining corneal transparency. This was further confirmed by the higher functional gene expression of collagen type 1, ALDH and lumican on cultured corneal keratocytes in 0.05% EBN supplemented medium (Figure 4). Collagen Type I is the major structural collagen of the cornea . On the other hand, ALDH catalyzed the oxidation of a wide variety of endogenous and exogenous aldehydes to their corresponding acids, with some ALDH have been identified as corneal crystallins which contribute to the protective and refractive properties of the cornea . The rabbit abundantly expresses ALDHs in its cornea . Lumican is essential for normal cornea morphogenesis during embryonic development and maintenance of corneal topography in adults. Lumican may have additional biological functions, such as modulation of cell migration and epithelium-mesenchyme transition in wound healing and regulating collagen fibrillogenesis .
Much of the work done in this study highlighted the potential use of EBN to treat corneal wound healing. It is indeed the first step in our aim for nutri-pharmaceutical formation of EBN-based eye drop prior to in vivo testing. The results successfully showed the EBN was safe to cornea and more importantly was able to produce cell proliferative activity of corneal keratocytes, optimally at 0.05% concentration. Further studies need to be done to elucidate the specific component of EBN which causes the mitogenic effects to corneal keratocytes. At the same time, there is a continuous need for more scientific researches to confirm the various health claims associated with EBN.
This study was supported by the UKM grant; FF-310-2010. The authors would like to thank the Faculty of Medicine, Universiti Kebangsaan Malaysia (National University of Malaysia) and Institute of Bioproduct Development, Universiti Teknologi Malaysia (UTM).
- Lu L, Reinach PS, Kao WWY: Corneal epithelial wound healing. Exp Biol Med. 2001, 226: 653-664.Google Scholar
- Krachmer JH, Mannis MJ, Holland EJ: Cornea: Fundamentals of cornea and external disease. 2004, Mosby-Year Book Publication, 183-195.Google Scholar
- West-Mays JA, Dwivedi DJ: The keratocyte: corneal stromal cell with variable repair phenotypes. International Journal of Biochemistry & Cell Biology. 2006, 38: 1625-1631.View ArticleGoogle Scholar
- He J, Bazan HEP: Epidermal growth factor synergism with TGF-β1 via PI-3 Kinase activity in corneal keratocyte differentiation. Invest Opthalmol Vis Sci. 2008, 49 (7): 2936-2945.View ArticleGoogle Scholar
- Fini ME: Keratocytes and fibroblast phenotypes in the repairing cornea. Prog Retin Eye Res. 1999, 18 (4): 529-551.View ArticlePubMedGoogle Scholar
- Poole CA, Brookes NH, Clover GM: Keratocyte networks visualized in the living cornea using vital dyes. J Cell Sci. 1993, 106: 685-692.PubMedGoogle Scholar
- Davison PF, Galbavy EJ: Connective tissue remodeling in corneal and scleral wounds. Invest Ophthalmol Vis Sci. 1986, 27: 1478-1484.PubMedGoogle Scholar
- Jester JV, Petroll WM, Cavanagh HD: Corneal stromal wound healing in refractive surgery: the role of myofibroblasts. Prog Retin Eye Res. 1999, 18: 311-356.View ArticlePubMedGoogle Scholar
- Fini ME, Streamer BM: How the corneal heals: cornea-specific repair mechanisms affecting surgical outcomes. Cornea. 2005, 24: 2-11.View ArticleGoogle Scholar
- Gnanadoss AS: Manual of cornea. 2008, Jaypee Bros. Medical Publishes (P) Ltd, 62-64.View ArticleGoogle Scholar
- West-Mays JA, Dwivedi DJ: The keratocyte: corneal stromal cell with variable repair phenotypes. International Journal of Biochemistry & Cell Biology. 2006, 38: 1625-1631.View ArticleGoogle Scholar
- Wilson SE, Netto M, Ambrosio R: Corneal cells: Chatty in development, homeostasis, wound healing, and disease. Am J Ophthalmol. 2003, 136 (3): 530-536.View ArticlePubMedGoogle Scholar
- Dayhaw-Barker P: Corneal Wound Healing II: The Process. ICLC. 1995, 110-116. 22Google Scholar
- Bartleh JD: Ophthalmic Drug Facts. 2009, Wolters Kluwer Health, 20Google Scholar
- Collin HB: Ultra structural changes to corneal stromal cells due to ophthalmic preservatives. Acta Ophthalmologica. 1986, 64 (1): 72-78.View ArticlePubMedGoogle Scholar
- Kong YC, Keung WM, Tip TT, Ko KK, Tsao SW, Ng MH: Evidence that epidermal growth factor is present in Swiflet's (Collocalia) nest. Comparative Biochemistry and Physiology. 1987, 87 (2): 221-226.PubMedGoogle Scholar
- Ng MH, Chan KH, Kong YC: Potentiation of mitogenicity response by extracts of swiftlet's (Collocalia) nest. Biochem Int. 1986, 13: 521-531.PubMedGoogle Scholar
- Yano S, Kondo K, Yamaguchi M, Richmond G, Hutchison M, Wakeling A, Averbuch S, Wadsworth P: Distribution and function of EGFR in human tissue and the effect of EGFR tyrosine kinase inhibition. Anticancer Res. 2003, 23: 3639-3650.PubMedGoogle Scholar
- Zhang M, Wang D, Wang J: The effects of the Zhenzhu-Yanwo extracts on animal function. Pharm Biotech. 1994, 1: 49-51.Google Scholar
- Guo C, Takahashi T, Bukawa W, Takahashi N, Yagi H, Kato K, Hidari KI-PJ, Miyamoto D, Suzuki T, Suzuki Y: Edible bird's nest extract inhibits influenza virus infection. Antiviral Research. 2006, 70: 140-146.View ArticlePubMedGoogle Scholar
- Aswir AR, Wan Nazaimoon WM: Effects of Edible Bird's Nest on Caco-2 Cell Proliferation. Journal of Food Technology. 2010, 3: 126-130.Google Scholar
- Oda M, Ohta S, Suga T, Aoki T: Study on Food Components: The Structure of N-Linked Asialo Carbohydrate from the Edible Bird's Nest Built by Collocalia fuciphaga. Journal of Agricultural and Food Chemistry. 1998, 3047-3053. 46Google Scholar
- Norzana AG, Ropilah AR, Jemaimah C, Chua KH, Fauziah O, Aminuddin BS, Ruszymah BHI: Rabbit limbal epithelial cells maintain its stemness in serum-free and feeder layer-free culture system. Tissue Engineering and Regenerative Medicine. 2007, 4: 557-565.Google Scholar
- Nur Fariha MM, Chua KH, Tan GC, Tan AE, Hayati AR: Human chorion-derived stem cells: changes in stem cell properties during serial passages. Cytotherapy. 2011, 13 (5): 582-593.View ArticleGoogle Scholar
- Woo HM, Kim MS, Kweon OK, Kim DY, Nam TC, Kim JH: Effects of amniotic membrane on epithelial wound healing and stromal remodeling after excimer laser keratectomy in rabbit cornea. Br J Ophthalmol. 2001, 85: 345-349.View ArticlePubMedPubMed CentralGoogle Scholar
- Shimmura S, Shimazaki J, Ohashi Y, Tsubota K: Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea. 2001, 20: 408-413.View ArticlePubMedGoogle Scholar
- Meller D, Pauklin M, Thomasen H, Westekemper H, Steulh K: Amniotic membrane transplantation in the human eye. Dtsch Arztebl Int. 2011, 108 (14): 243-248.PubMedPubMed CentralGoogle Scholar
- Imanishi J, Kamiyama K, Iguchi I, Kita M, Sotozono C, Kinoshita S: Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res. 2001, 19 (1): 113-129.View ArticleGoogle Scholar
- Pancholi S, Tollu A, Khaliq A, Foreman D, Boulton M: The effects of growth factors and conditioned media on the proliferation of human corneal epithelial cells and keratocytes. Graefe's Archieve for Clinical and Experimental Ophthalmology. 1998, 236 (1): 1-8.View ArticleGoogle Scholar
- Qin P, Kurpakus MA: The role of laminin-5 in TGF-alpha/EGF-mediated corneal epithelial cell motility. Exp Eye Res. 1998, 66 (5): 569-579.View ArticlePubMedGoogle Scholar
- Heather CB, Marshall J: Growth factors in corneal wound healing following refractive surgery: a review. Acta Ophthalmologica. 2002, 80 (3): 238-247.View ArticleGoogle Scholar
- Colombo JP, Garcia-Rodenas C, Guesry PR, Rey J: Potential effects of supplementation with amino acids, choline or sialic acid on cognitive development in young infants. Acta Paediatrica. 2003, 92: 42-46.View ArticlePubMedGoogle Scholar
- Dhawan S, Kuhad RC: Effect of amino acids and vitamins on laccase production by the bird's nest fungus. Cyathus bulleri Bioresour Technol. 2002, 84: 35-38.View ArticlePubMedGoogle Scholar
- Sam CT, Tan PH, Lim CH: Establishing the authenticity of edible bird's nest. ISFM Medicine Scientific Review. 1991, 3: 1-4.Google Scholar
- Kathan RII, Weeks DI: Structure studies of collocalia mucoid. I. Carbohydrate and amino acid composition. Arch Biochem Biophys. 1969, 134: 572-576.View ArticlePubMedGoogle Scholar
- Cotran RS, Kumar V, Fausto N, Robbins SL, Abbas AK: Robbins & Cotran pathologic basis of disease. 2005, Elsevier SaundersGoogle Scholar
- Andresen JL, Ledet T, Ehlars N: Keratocyte migration and peptide growth factors: the effect of PDGF, bFGF, EGF, IGF-I, aFGF and TGF-β on human keratocyte migration in a collagen gel. Curr Eye Res. 1997, 16: 605-613.View ArticlePubMedGoogle Scholar
- Pancholi S, Tullo A, Khaliq A, Foreman D: The effects of growth factors and conditioned media on the proliferation of human corneal epithelial cells and keratocytes. Graefe's Arch Clin Exp Opthalmo. 1998, 236: 1-8.View ArticleGoogle Scholar
- Nardone RM: Cell culture methodology from donor to cell lines. BioTechniques. 1987, 5: 122-127.Google Scholar
- Butler M, Jenkins H: Nutritional aspects of the growth of animal cells in culture. J Biotechnol. 1989, 12: 97-110.View ArticleGoogle Scholar
- Freshney RI: Culture of Animal Cells: A Manual of Basic Technique. 1994, NewYork: Wiley-Liss, Inc, 3Google Scholar
- Mizrahi A, Lazar A: Media for cultivation of animal cells: An Overview. Cytotechnology. 1988, 1: 199-214.PubMedGoogle Scholar
- Barnes D, Sato G: Serum-free cell culture: a unifying approach. Cell. 1980, 24: 649-655.View ArticleGoogle Scholar
- Masters JRW: Animal Cell Culture. A Practical Approach. 2000, Oxford University Press, 3Google Scholar
- Davis JM: Basic Cell Culture. A Practical Approach. 2002, Oxford University Press, 2Google Scholar
- Dalili M, Ollis DF: Transient kinetics of hybridoma growth and monoclonal antibody production m serum-limited cultures. Eiotechnol Bioeng. 1989, 33: 984-990.View ArticleGoogle Scholar
- Glacken MW, Adema E, Sinskey AJ: Mathematical descriptions of hybridoma culture kinetics. II. The relationship between thiol chemistry and the degradation of serum activity. Biotechnol Bioeng. 1989, 33: 440-450.View ArticlePubMedGoogle Scholar
- Lee GM, Huard TK, Palsson BO: Effect of serum concentration on hybridoma cell growth and monoclonal antibody production at various initial cell densities. Hybridonto. 1989, 3: 369-375.View ArticleGoogle Scholar
- Zimmermann DR, Treub B, Winterhalter KH, Witmer R, Fischer RW: Type VI collagen is a major component of the human cornea. FEBS (Fed Euir Biochem Soc) Lett. 1986, 197: 55-58.View ArticleGoogle Scholar
- Mahin A, Tilly P, Elizabeth MA, Roger SH: Bovine corneal aldehyde dehydrogenase: The major soluble corneal protein with a possible dual protective role for the eye. Experimental Eye Research. 1990, 51 (4): 419-426.View ArticleGoogle Scholar
- Kao WW, Liu CY: Roles of lumican and keratocan on corneal transparency. Glycoconj J. 2002, 19 (4-5): 275-285.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/11/94/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.